Fortis Healthcare Subsidiary Receives ₹597.93 Crore GST Demand Order
Fortis Healthcare's subsidiary Fortis Health Management Limited received a GST order demanding ₹597.93 crores for FY 2023-24, comprising principal demand, interest of ₹79.29 crores, and penalty of ₹259.32 crores. The demand stems from denial of healthcare service GST exemption. The company plans to appeal the order and expects no material financial impact.

*this image is generated using AI for illustrative purposes only.
Fortis Healthcare Limited has informed stock exchanges about a significant GST order received by its wholly owned subsidiary, Fortis Health Management Limited, demanding ₹597.93 crores including interest and penalty for the financial year 2023-24.
GST Order Details
The State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu issued the GST order on January 02, 2026. The order follows a show cause notice that was initially issued for ₹570.00 crores, including a penalty of ₹285.00 crores.
| Component | Amount (₹ Crores) |
|---|---|
| Principal Demand | ₹259.32 |
| Interest | ₹79.29 |
| Penalty | ₹259.32 |
| Total Demand | ₹597.93 |
Nature of Dispute
The GST authority has denied the healthcare service exemption claimed by the company. According to the disclosure, the GST exemption of healthcare service claimed by Fortis Health Management Limited has been rejected, leading to the demand confirmation.
Company's Response
Fortis Healthcare has indicated that after submission of response by Fortis Health Management Limited, the GST Authority passed the order confirming the higher demand amount. The show cause notice in relation to the balance amount has been dropped by the authorities.
Financial Impact Assessment
The company has assessed that the demand is not maintainable and is in the process of filing an appeal against the order. Management has stated that it does not envisage any relevant impact on the financials, operations, or other activities of the company.
| Parameter | Details |
|---|---|
| Order Date | January 02, 2026 |
| Financial Year | 2023-24 |
| Expected Impact | No material impact anticipated |
| Next Step | Appeal to be filed |
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided detailed annexures covering the litigation details and penalty information as required under the regulatory framework.
The disclosure was signed by Satyendra Chauhan, Company Secretary & Compliance Officer, and submitted to both NSE and BSE on January 02, 2026.
Historical Stock Returns for Fortis Malar Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.87% | +1.26% | -5.98% | -17.35% | -1.50% | +8.37% |




































